Comparison of the inhibitory potencies of N(G)-methyl-, N(G)-nitro- and N(G)-amino-L-arginine on EDRF function in the rat: evidence for continuous basal EDRF release

HM Vargas, JM Cuevas, LJ Ignarro and G Chaudhuri

Department of Pharmacology, University of California School of Medicine, Los Angeles.

The relative potencies of the argininolytic agents NG-methyl-L-arginine (L-NMA), NG-nitro-L-arginine (L-NNA) and NG-amino-L-arginine (L-NAA) were assayed by their inhibitory effect on both basal and stimulated release of endothelium-derived NO in vitro and in vivo. Basal NO release was indirectly assessed by the ability of the analogs to contract phenylephrine-preconstricted rat aortic rings and their ability to produce a hypertensive response in awake, unanesthetized normotensive rats. In aortic rings, the three analogs induced vasocontraction and inhibited the vasorelaxation mediated by ACh- stimulated endothelial NO release. In this latter assay, L-NNA was 30 times more potent than either L-NMA or L-NAA. In free-moving rats, the agents caused dose-dependent increases in arterial pressure due to the blockade of endogenous NO formation. Dose-response analysis indicated that L-NNA was 87 and 230 times more potent than L-NMA and L-NAA, respectively. Pretreatment with L-NNA was also found to selectively inhibit, but not abolish, the depressor effects of acetylcholine in unanesthetized and phenylephrine- or vasopressin-infused normotensive- pithed rats. These studies indicate that L-NNA is a potent antagonist of endothelium-derived relaxing factor formation in vitro and in vivo. The contractile and hypertensive effects of the argininolytic agents clearly demonstrates that a continuous basal release of endothelium- derived relaxing factor/NO occurs in both isolated vascular rings and whole animals.

Volume 257, Issue 3, pp. 1208-1215, 06/01/1991
Copyright © 1991 by American Society for Pharmacology and Experimental Therapeutics

This article has been cited by other articles:

				W. G. Schrage, M. J. Joyner, and F. A. Dinenno Local inhibition of nitric oxide and prostaglandins independently reduces forearm exercise hyperaemia in humans J. Physiol., June 1, 2004; 557(2): 599 - 611. [Abstract] [Full Text] [PDF]

				S. Mateev, A. H. Sillau, R. Mouser, R. E. McCullough, M. M. White, D. A. Young, and L. G. Moore Chronic hypoxia opposes pregnancy-induced increase in uterine artery vasodilator response to flow Am J Physiol Heart Circ Physiol, March 1, 2003; 284(3): H820 - H829. [Abstract] [Full Text] [PDF]

				A. H. Sillau, R. E. McCullough, R. Dyckes, M. M. White, and L. G. Moore Chronic hypoxia increases MCA contractile response to U-46619 by reducing NO production and/or activity J Appl Physiol, May 1, 2002; 92(5): 1859 - 1864. [Abstract] [Full Text] [PDF]

				C. A. Mastronardi, W. H. Yu, and S. M. McCann Resting and circadian release of nitric oxide is controlled by leptin in male rats PNAS, April 16, 2002; 99(8): 5721 - 5726. [Abstract] [Full Text] [PDF]

				K. Thomsen, I. Rubin, and M. Lauritzen In vivo mechanisms of acetylcholine-induced vasodilation in rat sciatic nerve Am J Physiol Heart Circ Physiol, September 1, 2000; 279(3): H1044 - H1054. [Abstract] [Full Text] [PDF]

				R. Wiest, V. Shah, W. C. Sessa, and R. J. Groszmann NO overproduction by eNOS precedes hyperdynamic splanchnic circulation in portal hypertensive rats Am J Physiol Gastrointest Liver Physiol, April 1, 1999; 276(4): G1043 - G1051. [Abstract] [Full Text] [PDF]

				R.-S. Zhang, P. H. Guth, O. U. Scremin, R. Singh, S. Pervin, and G. Chaudhuri Regulation of endometrial blood flow in ovariectomized rats: assessment of the role of nitric oxide Am J Physiol Heart Circ Physiol, October 1, 1997; 273(4): H2009 - H2017. [Abstract] [Full Text] [PDF]

				G.-W. He and C.-Q. Yang Basal or Stimulated Release?: Evidence of EDRF (NO) Release by TP-Receptor Agonist U46619 Vascular and Endovascular Surgery, July 1, 1997; 31(4): 433 - 439. [Abstract] [PDF]

				L. Puybasset, M.-L. Bea, B. Ghaleh, J.-F. Giudicelli, and A. Berdeaux Coronary and Systemic Hemodynamic Effects of Sustained Inhibition of Nitric Oxide Synthesis in Conscious Dogs: Evidence for Cross Talk Between Nitric Oxide and Cyclooxygenase in Coronary Vessels Circ. Res., August 1, 1996; 79(2): 343 - 357. [Abstract] [Full Text]

				R. Tatchum-Talom, N. Niederhoffer, F. Amin, T. Makki, P. Tankosic, and J. Atkinson Aortic Stiffness and Left Ventricular Mass in a Rat Model of Isolated Systolic Hypertension Hypertension, December 1, 1995; 26(6): 963 - 970. [Abstract] [Full Text]

				G.-W. He and C.-Q. Yang "Vasoactivators"--a New Concept for Naturally Secreted vasoconstrictor Substances Angiology, April 1, 1994; 45(4): 265 - 271. [Abstract] [PDF]